Report Detail
Global Pharmacokinetics Services Market Size, Status and Forecast 2019-2025
- RnM3199527 |
- 21 May, 2020 |
- Global |
- 96 Pages |
- QYResearch |
- Other
This report covers market size and forecasts of Pharmacokinetics Services, including the following market information:
Global Pharmacokinetics Services Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pharmacokinetics Services Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pharmacokinetics Services Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Pharmacokinetics Services Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg), Frontage Labs (US), SGS SA (Switzerland), LGC Limited (UK), Creative Bioarray (US), Certara, L.P. (Germany), etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Based on the Application:
Small & Medium Enterprise
Large Enterprise
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Pharmacokinetics Services Quarterly Market Size Analysis
- 2.1 Pharmacokinetics Services Business Impact Assessment - COVID-19
- 2.1.1 Global Pharmacokinetics Services Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Pharmacokinetics Services Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Pharmacokinetics Services Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Pharmacokinetics Services Headquarters and Area Served
- 3.3 Date of Key Players Enter into Pharmacokinetics Services Market
- 3.4 Key Players Pharmacokinetics Services Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Pharmacokinetics Services Segments, By Type
- 4.1 Introduction
- 1.4.1 Small Molecules Pharmacokinetics Services
- 1.4.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
- 4.2 By Type, Global Pharmacokinetics Services Market Size, 2019-2021
5 Impact of Covid-19 on Pharmacokinetics Services Segments, By Application
- 5.1 Overview
- 5.5.1 Small & Medium Enterprise
- 5.5.2 Large Enterprise
- 5.2 By Application, Global Pharmacokinetics Services Market Size, 2019-2021
- 5.2.1 By Application, Global Pharmacokinetics Services Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Evotec AG (Germany)
- 7.1.1 Evotec AG (Germany) Business Overview
- 7.1.2 Evotec AG (Germany) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.1.3 Evotec AG (Germany) Pharmacokinetics Services Product Introduction
- 7.1.4 Evotec AG (Germany) Response to COVID-19 and Related Developments
- 7.2 Pacific BioLabs (US)
- 7.2.1 Pacific BioLabs (US) Business Overview
- 7.2.2 Pacific BioLabs (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product Introduction
- 7.2.4 Pacific BioLabs (US) Response to COVID-19 and Related Developments
- 7.3 GVK Biosciences Private Limited (India)
- 7.3.1 GVK Biosciences Private Limited (India) Business Overview
- 7.3.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Introduction
- 7.3.4 GVK Biosciences Private Limited (India) Response to COVID-19 and Related Developments
- 7.4 Shanghai Medicilon Inc. (China)
- 7.4.1 Shanghai Medicilon Inc. (China) Business Overview
- 7.4.2 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Introduction
- 7.4.4 Shanghai Medicilon Inc. (China) Response to COVID-19 and Related Developments
- 7.5 Pharmaceutical Product Development, LLC (US)
- 7.5.1 Pharmaceutical Product Development, LLC (US) Business Overview
- 7.5.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Introduction
- 7.5.4 Pharmaceutical Product Development, LLC (US) Response to COVID-19 and Related Developments
- 7.6 Charles River Laboratories International, Inc. (US)
- 7.6.1 Charles River Laboratories International, Inc. (US) Business Overview
- 7.6.2 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Introduction
- 7.6.4 Charles River Laboratories International, Inc. (US) Response to COVID-19 and Related Developments
- 7.7 PAREXEL International Corporation (US)
- 7.7.1 PAREXEL International Corporation (US) Business Overview
- 7.7.2 PAREXEL International Corporation (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product Introduction
- 7.7.4 PAREXEL International Corporation (US) Response to COVID-19 and Related Developments
- 7.8 Eurofins Scientific, Inc. (Luxembourg)
- 7.8.1 Eurofins Scientific, Inc. (Luxembourg) Business Overview
- 7.8.2 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Introduction
- 7.8.4 Eurofins Scientific, Inc. (Luxembourg) Response to COVID-19 and Related Developments
- 7.9 Frontage Labs (US)
- 7.9.1 Frontage Labs (US) Business Overview
- 7.9.2 Frontage Labs (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.9.3 Frontage Labs (US) Pharmacokinetics Services Product Introduction
- 7.9.4 Frontage Labs (US) Response to COVID-19 and Related Developments
- 7.10 SGS SA (Switzerland)
- 7.10.1 SGS SA (Switzerland) Business Overview
- 7.10.2 SGS SA (Switzerland) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product Introduction
- 7.10.4 SGS SA (Switzerland) Response to COVID-19 and Related Developments
- 7.11 LGC Limited (UK)
- 7.11.1 LGC Limited (UK) Business Overview
- 7.11.2 LGC Limited (UK) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.11.3 LGC Limited (UK) Pharmacokinetics Services Product Introduction
- 7.11.4 LGC Limited (UK) Response to COVID-19 and Related Developments
- 7.12 Creative Bioarray (US)
- 7.12.1 Creative Bioarray (US) Business Overview
- 7.12.2 Creative Bioarray (US) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.12.3 Creative Bioarray (US) Pharmacokinetics Services Product Introduction
- 7.12.4 Creative Bioarray (US) Response to COVID-19 and Related Developments
- 7.13 Certara, L.P. (Germany)
- 7.13.1 Certara, L.P. (Germany) Business Overview
- 7.13.2 Certara, L.P. (Germany) Pharmacokinetics Services Quarterly Revenue, 2020
- 7.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product Introduction
- 7.13.4 Certara, L.P. (Germany) Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
Summary:
Get latest Market Research Reports on Pharmacokinetics Services . Industry analysis & Market Report on Pharmacokinetics Services is a syndicated market report, published as Global Pharmacokinetics Services Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pharmacokinetics Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
